United States v. Kang

715 F. Supp. 2d 657, 2010 U.S. Dist. LEXIS 53003, 2010 WL 2163095
CourtDistrict Court, D. South Carolina
DecidedMay 27, 2010
DocketCriminal No.: 9:05-cr-00928
StatusPublished
Cited by3 cases

This text of 715 F. Supp. 2d 657 (United States v. Kang) is published on Counsel Stack Legal Research, covering District Court, D. South Carolina primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
United States v. Kang, 715 F. Supp. 2d 657, 2010 U.S. Dist. LEXIS 53003, 2010 WL 2163095 (D.S.C. 2010).

Opinion

ORDER and OPINION

DAVID C. NORTON, Chief Judge.

This matter is before the court on defendants’ motion for judgment of acquittal under Federal Rule of Criminal Procedure 29. On February 18, 2010, defendants filed their motion at the close of the government’s case. The government filed a response in opposition to defendants’ motion on February 19, 2010. The court heard argument on the motion and took the matter under advisement. Following a jury verdict of guilty as to both defendants, the court requested that the parties submit supplemental briefing on this matter. On April 13, 2010, the court heard argument on the issue of whether the statute of limitations had run and that the prosecution of defendants for the alleged conspiracy was untimely. For the reasons set forth below, the court holds that the statute of limitations for the conspiracy charged in Count One of the Second Superseding Indictment had expired because the objectives of the conspiracy were achieved with the Medical Manager/Synetic/WebMD merger in September 2000, and the overt acts relied on by both the government and the jury may not “properly be regarded as in furtherance of the conspiracy.” Grun ewald v. United States, 353 U.S. 391, 397, 77 S.Ct. 963, 1 L.Ed.2d 931 (1957).

I. BACKGROUND

On December 15, 2005, a grand jury returned a seven count superseding indictment against officers and/or employees of Medical Manager Corporation, 1 including Messrs. John H. Kang and John P. Sessions. The indictment charged all defendants with conspiracy to commit mail, wire, and securities fraud in violation of Title 18, United States Code, Section 371. 2 The indictment also charged all defendants with conspiracy to commit money laundering in violation of Title 18, United States Code, Section 1956(h). The indictment charged Mr. Sessions individually with five counts of money laundering in violation of Title 18, United States Code, Section 1957. 3 On February 27, 2007, a Second Superseding Indictment was re *660 turned. In that indictment, the government alleged 119 overt acts in furtherance of the conspiracy to commit mail, wire, and securities fraud.

The Second Superseding Indictment alleges five principal purposes to the alleged conspiracy:

(a) to manipulate the revenue and earnings of Medical Manager in order to fraudulently inflate the market price of Medical Manager and WebMD stock;
(b) to make Medical Manager an artificially attractive acquisition target;
(c) to use the fraudulently inflated price of Medical Manager stock to facilitate the acquisition of target companies by Medical Manager which in turn would enable further fraudulent inflation of Medical Manager’s earnings;
(d) to conceal such fraud by:
(i) making false statements to Medical Manager and WebMD executives, outside auditors, and investigators;
(ii) concealing evidence of their and their conspirators’ misconduct from Medical Manager and WebMD execufives, investigators, and outside auditors; and
(iii)continuing to meet analyst expectations through fraudulent means; and
(e)to personally enrich the defendants and others through various means including but not limited to, salary, bonuses, stock option grants, and capital appreciation of their Medical Manager and WebMD stock.

(Second Superseding Indictment ¶ 26.)

In Spring 2009, after years of discovery, legal maneuvering, and various other obstacles, the case began moving towards trial. 4 Numerous pre-trial motions were filed, and the court and the parties estimated the trial would last four to six months. As a result of the demands of the anticipated lengthy trial, in August 2009, the case was transferred to the undersigned who scheduled the trial to begin on January 19, 2010.

Surprisingly, after four years under indictment and shortly before trial, the government dismissed several defendants. 5 *661 On November 25, 2009, the court granted the government’s motion to dismiss the indictment against Mr. Dorman. On December 22, 2009, the court granted the government’s motion to dismiss the indictment against Mr. Karl. On December 22, 2009, 2009 WL 5194991, the court also granted Mr. Krieger’s motions to sever and for change of venue, and transferred his case to the Middle District of Florida. On December 23, 2009, the court granted the government’s motion to dismiss the indictment against Mr. Ward. Additionally, on January 12, 2010, the same day as jury selection, the government and Mr. Singer 6 entered into a deferred prosecution agreement. 7

On January 19, 2010, a jury trial began with the two remaining defendants, Mr. Kang and Mr. Sessions. At the conclusion of the trial, the court instructed the jury on the applicable law and provided each juror with a copy of the instructions. The closing instructions included a jointly agreed-upon list of the overt acts the jury could consider. Of the eighty-two acts listed in the instructions, only the following four occurred within the statute of limitations period:

166. During an interview with WebMD’s lawyers on or about July 15, 2003, Sessions concealed the nature of the accounting fraud at Medical Manager, specifically that certain Dealer acquisitions were structured with the specific intent of securing the financial results necessary to make quarterly revenue and earnings targets.
167. During :an interview with WebMD’s-lawyers on or about July 15, 2003, Sessions concealed his own involvement in another fraudulent transaction, the Raven deal, and provided a false version of what occurred.
168. During an interview with WebMD’s lawyers on or about August 26, 2003, Kang stated falsely that: a) Medical Manager’s acquisitions were always recorded in accordance with generally accepted accounting principles; b) the Dealer acquisitions were always presented to the auditors before being recorded in Medical Manager’s accounting system; and c) concealed the fact that specific Dealer acquisitions were structured specifically to make the quarterly revenue and earnings targets.
169. During an interview with WebMD’s lawyers on or about August *662 26, 2003, Kang further concealed his own involvement with the Raven deal and the fact that the deal was fraudulently structured to falsely inflate Medical Manager’s revenue and earnings.

(Second Superseding Indictment ¶¶ 166-169.)

Free access — add to your briefcase to read the full text and ask questions with AI

Related

United States v. Magalnik
160 F. Supp. 3d 909 (W.D. Virginia, 2015)
United States v. Hong Vo
978 F. Supp. 2d 49 (District of Columbia, 2013)
United States v. Leonard
777 F. Supp. 2d 1025 (W.D. Virginia, 2011)

Cite This Page — Counsel Stack

Bluebook (online)
715 F. Supp. 2d 657, 2010 U.S. Dist. LEXIS 53003, 2010 WL 2163095, Counsel Stack Legal Research, https://law.counselstack.com/opinion/united-states-v-kang-scd-2010.